-
EP2318419
European procedure
Extract from the Register of European Patents
EP About this file: EP2318419
| EP2318419 - BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF [Right-click to bookmark this link] | Status | Patent maintained as amended Status updated on 27.09.2024 Database last updated on 26.04.2025 | Most recent event Tooltip | 27.09.2024 | Patent maintained (B2 publication) | published on 30.10.2024 [2024/44] | Applicant(s) | For all designated states Takeda Pharmaceutical Company Limited 1-1, Doshomachi 4-chome Chuo-ku Osaka 540-8645 / JP | [2023/12] |
| Former [2011/19] | For all designated states Millennium Pharmaceuticals, Inc. 40 Landsdowne Street Cambridge, MA 02139 / US | Inventor(s) | 01 /
ELLIOTT, Eric, L. 35 N. Crescent Circuit Brighton MA 02135 / US | 02 /
FERDOUS, Abu, J. 5 Squire Road Winchester MA 01890 / US | 03 /
KAUFMAN, Michael, J. 230 Waltham Street Lexington MA 02421 / US | 04 /
KOMAR, Sonja, A. 68 Thomas Street Belmont MA 02478 / US | 05 /
MAZAIK, Debra, L. 125 Wilson Street Holliston MA 01746 / US | 06 /
MCCUBBIN, Quentin, J. 58 Pinehurst Road Belmont MA 02478 / US | 07 /
NGUYEN, Phoung, M. 126 Gore Street 4 Cambridge MA 02141 / US | 08 /
PALANIAPPAN, Vaithianathan 7 Spruce Circle Andover MA 01810 / US | 09 /
SKWIERCZYNSKI, Raymond, D. 122 Salem Street Andover MA 01810 / US | 10 /
TRUONG, Nobel, T. 26 Stallbrook Street Milford MA 01757 / US | 11 /
VARGA, Csanad, M. 83 Commonwealth Park W Newton MA 02459 / US | 12 /
ZAWANEH, Peter, N. 854 Massachusetts Avenue 12 Cambridge MA 02139 / US | [2014/43] |
| Former [2011/19] | 01 /
ELLIOTT, Eric, L. 35 N. Crescent Circuit Brighton MA 02135 / US | ||
| 02 /
FERDOUS, Abu, J. 5 Squire Road Winchester MA 01890 / US | |||
| 03 /
KAUFMAN, Michael, J. 230 Waltham Street Lexington MA 02421 / US | |||
| 04 /
KOMAR, Sonja, A. 68 Thomas Street Belmont MA 02478 / US | |||
| 05 /
MAZAIK, Debra, L. 44 Pleasant Street Hopkinton MA 01748 / US | |||
| 06 /
MCCUBBIN, Quentin, J. 104 Cross Street Belmont MA 02478 / US | |||
| 07 /
NGUYEN, Phoung, M. 129 Franklin Street, No. 218 Cambridge MA 02139 / US | |||
| 08 /
PALANIAPPAN, Vaithianathan 7 Spruce Circle Andover MA 01810 / US | |||
| 09 /
SKWIERCZYNSKI, Raymond, D. 122 Salem Street Andover MA 01810 / US | |||
| 10 /
TRUONG, Nobel, T. 26 Stallbrook Street Milford MA 01757 / US | |||
| 11 /
VARGA, Csanad, M. 95 Jackson Street Cambridge MA 02140 / US | |||
| 12 /
ZAWANEH, Peter, N. 854 Massachusetts Avenue 12 Cambridge MA 02139 / US | Representative(s) | Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [2024/44] |
| Former [2011/19] | Harris, Jennifer Lucy, et al Kilburn & Strode LLP 20 Red Lion Street London WC1R 4PJ / GB | Application number, filing date | 09767050.9 | 16.06.2009 | [2011/19] | WO2009US03602 | Priority number, date | US20080132244P | 17.06.2008 Original published format: US 132244 P | US20090211499P | 31.03.2009 Original published format: US 211499 P | [2011/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2009154737 | Date: | 23.12.2009 | Language: | EN | [2009/52] | Type: | A1 Application with search report | No.: | EP2318419 | Date: | 11.05.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.12.2009 takes the place of the publication of the European patent application. | [2011/19] | Type: | B1 Patent specification | No.: | EP2318419 | Date: | 08.04.2015 | Language: | EN | [2015/15] | Type: | B2 New European patent specification | No.: | EP2318419 | Date: | 30.10.2024 | Language: | EN | [2024/44] | Search report(s) | International search report - published on: | EP | 23.12.2009 | Classification | IPC: | C07F5/02, C07F5/04, C07F5/06, A61K38/05, A61P35/00, A61P29/00, C07K5/06, C07K5/078 | [2014/13] | CPC: |
C07K5/06139 (EP,CN,US);
A61K31/69 (EP,CN,KR,US);
C07F5/04 (EP,CN,KR,US);
A61K31/198 (EP,CN,US);
A61K31/454 (EP,CN,US);
A61K47/183 (CN);
A61K9/0019 (CN);
A61K9/19 (CN);
A61P1/00 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/02 (EP);
A61P25/00 (EP);
A61P25/04 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/28 (EP);
A61P27/02 (EP);
A61P29/00 (EP);
A61P31/00 (EP);
A61P31/18 (EP);
A61P35/00 (EP);
A61P35/02 (EP);
A61P35/04 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P43/00 (EP);
A61P7/06 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
C07C233/83 (EP,US);
C07F5/02 (CN);
C07F5/025 (EP,CN,US);
C07F5/05 (KR);
| C-Set: |
A61K31/198, A61K2300/00 (CN);
A61K31/454, A61K2300/00 (CN);
A61K31/69, A61K2300/00 (CN)
|
| Former IPC [2011/19] | C07F5/02, C07F5/04, C07F5/06, A61K38/05, A61P35/00, A61P29/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2024/44] |
| Former [2011/19] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Extension states | AL | 17.01.2011 | BA | 17.01.2011 | RS | 17.01.2011 | Title | German: | BORONATESTERVERBINDUNGEN UND PHARMAZEUTISCHE ZUSAMMENSETZUNGEN DAVON | [2011/19] | English: | BORONATE ESTER COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF | [2011/19] | French: | COMPOSÉS DE BORATES ESTERS ET COMPOSITIONS PHARMACEUTIQUES CONTENANT DES COMPOSÉS | [2011/19] | Entry into regional phase | 17.01.2011 | National basic fee paid | 17.01.2011 | Designation fee(s) paid | 17.01.2011 | Examination fee paid | Examination procedure | 17.01.2011 | Examination requested [2011/19] | 26.04.2011 | Amendment by applicant (claims and/or description) | 25.10.2011 | Despatch of a communication from the examining division (Time limit: M06) | 04.05.2012 | Reply to a communication from the examining division | 17.03.2014 | Communication of intention to grant the patent | 14.07.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 04.08.2014 | Communication of intention to grant the patent | 20.08.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 28.10.2014 | Communication of intention to grant the patent | 18.02.2015 | Fee for grant paid | 18.02.2015 | Fee for publishing/printing paid | 27.02.2015 | Receipt of the translation of the claim(s) | Divisional application(s) | EP13191409.5 / EP2730579 | EP13191412.9 / EP2730580 | EP13191413.7 / EP2733147 | EP13191414.5 / EP2730581 | EP19150417.4 / EP3536693 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 25.10.2011 | Opposition(s) | Opponent(s) | 01
08.01.2016
20.01.2016
ADMISSIBLE Generics (U.K.) Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative FRKelly, et al, et al Waterways House Grand Canal Quay Dublin D02 PD39 / IE | 02
08.01.2016
20.01.2016
ADMISSIBLE Actavis Group PTC ehf Reykjavikurvegi 76-78 220 Hafnarfjördur / IS Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | 03
08.01.2016
20.01.2016
ADMISSIBLE Teva Pharmaceutical Industries Ltd 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | [N/P] |
| Former [2021/47] | |||
| Opponent(s) | 01
08.01.2016
20.01.2016
ADMISSIBLE Generics (U.K.) Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative FRKelly, et al, et al 27 Clyde Road Dublin D04 F838 / IE | ||
| 02
08.01.2016
20.01.2016
ADMISSIBLE Actavis Group PTC ehf Reykjavikurvegi 76-78 220 Hafnarfjördur / IS Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
| 03
08.01.2016
20.01.2016
ADMISSIBLE Teva Pharmaceutical Industries Ltd 124 Dvora HaNevi'a St. 6944020 Tel Aviv / IL Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2021/20] | |||
| Opponent(s) | 01
08.01.2016
20.01.2016
ADMISSIBLE Generics (U.K.) Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative FRKelly, et al, et al 27 Clyde Road Dublin D04 F838 / IE | ||
| 02
08.01.2016
20.01.2016
ADMISSIBLE Actavis Group PTC ehf Reykjavikurvegi 76-78 220 Hafnarfjördur / IS Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
| 03
08.01.2016
20.01.2016
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street P.O. Box 3190 49131 Petah Tiqva / IL Opponent's representative Hamm&Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2017/40] | |||
| Opponent(s) | 01
08.01.2016
20.01.2016
ADMISSIBLE Generics (U.K.) Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative FRKelly, et al, et al 27 Clyde Road Dublin D04 F838 / IE | ||
| 02
08.01.2016
20.01.2016
ADMISSIBLE Actavis Group PTC ehf Reykjavikurvegi 76-78 220 Hafnarfjördur / IS Opponent's representative Hamm & Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
| 03
08.01.2016
20.01.2016
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street P.O. Box 3190 49131 Petah Tiqva / IL Opponent's representative Hamm & Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2017/02] | |||
| Opponent(s) | 01
08.01.2016
20.01.2016
ADMISSIBLE Generics (U.K.) Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative O'Connell, Maura, et al, et al FRKelly 27 Clyde Road Dublin D04 F838 / IE | ||
| 02
08.01.2016
20.01.2016
ADMISSIBLE Actavis Group PTC ehf Reykjavikurvegi 76-78 220 Hafnarfjördur / IS Opponent's representative Hamm & Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
| 03
08.01.2016
20.01.2016
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street P.O. Box 3190 49131 Petah Tiqva / IL Opponent's representative Hamm & Wittkopp Patentanwälte PartmbB, et al, et al Jungfernstieg 38 20354 Hamburg / DE | |||
| Former [2016/13] | |||
| Opponent(s) | 01
08.01.2016
20.01.2016
ADMISSIBLE Generics (U.K.) Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative O'Connell, Maura, et al, et al FRKelly 27 Clyde Road Ballsbridge Dublin 4 / IE | ||
| 02
08.01.2016
20.01.2016
ADMISSIBLE Actavis Group PTC ehf Reykjavikurvegi 76-78 220 Hafnarfjördur / IS Opponent's representative Hamm & Wittkopp Patentanwälte PartmbB Jungfernstieg 38 20354 Hamburg / DE | |||
| 03
08.01.2016
20.01.2016
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street P.O. Box 3190 49131 Petah Tiqva / IL Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | |||
| Former [2016/08] | |||
| Opponent(s) | 01
08.01.2016
20.01.2016
ADMISSIBLE Generics (U.K.) Limited Station Close Potters Bar Hertfordshire EN6 1TL / GB Opponent's representative O'Connell, Maura, et al, et al FRKelly 27 Clyde Road Ballsbridge Dublin 4 / IE | ||
| 02
08.01.2016
20.01.2016
ADMISSIBLE Actavis PTC ehf Reykjavikurvegur 76-78 220 Hafnarfjordur / IS Opponent's representative von Seebach, Malte, et al, et al Maiwald Patentanwalts GmbH Jungfernstieg 38 20354 Hamburg / DE | |||
| 03
08.01.2016
20.01.2016
ADMISSIBLE Teva Pharmaceutical Industries Ltd 5 Basel Street P.O. Box 3190 49131 Petah Tiqva / IL Opponent's representative Teipel, Stephan, et al, et al Lederer & Keller Patentanwälte Partnerschaft mbB Unsöldstrasse 2 80538 München / DE | 16.02.2016 | Invitation to proprietor to file observations on the notice of opposition | 26.10.2016 | Reply of patent proprietor to notice(s) of opposition | 18.09.2017 | Date of oral proceedings | 16.10.2017 | Despatch of minutes of oral proceedings | 28.10.2022 | Despatch of a communication from the opposition division (Time limit: M02) | 21.12.2022 | Reply to a communication from the opposition division | 09.11.2023 | Despatch of a communication from the opposition division (Time limit: M02) | 15.03.2024 | Despatch of interlocutory decision in opposition | 15.03.2024 | Legal effect of interlocutory decision in opposition | 20.06.2024 | Despatch of communication that the patent will be maintained as amended | Appeal following opposition | 19.12.2017 | Appeal received No. T2785/17 | 26.02.2018 | Statement of grounds filed | 23.06.2022 | Result of appeal procedure: maintenance in amended form | 06.10.2022 | Despatch of the decision of the Board of Appeal | 23.06.2022 | Date of oral proceedings | Fees paid | Renewal fee | 27.06.2011 | Renewal fee patent year 03 | 31.03.2012 | Renewal fee patent year 04 | 27.06.2013 | Renewal fee patent year 05 | 30.06.2014 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO02059130 (US HEALTH [US]); | [X]US2002188100 (PLAMONDON LOUIS [US], et al); | [X]US2005282742 (PLAMONDON LOUIS [US], et al) | Opposition | WO02059131 | WO2005021558 | US2007185060 | WO9613266 | US5780454 | WO02059130 | WO02096933 | US2002188100 | WO03105860 | US6713446 | WO2004064755 | WO2005016859 | US2005282742 | WO2006086600 | WO2009020448 |